ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
88.28 EUR
-1.44 (-1.6%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- ABL had positive earnings in the past year.
- ABL had a positive operating cash flow in the past year.
- ABL had positive earnings in each of the past 5 years.
- In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 7.52%, ABL belongs to the best of the industry, outperforming 85.25% of the companies in the same industry.
- ABL's Return On Equity of 12.51% is amongst the best of the industry. ABL outperforms 80.33% of its industry peers.
- The Return On Invested Capital of ABL (9.17%) is better than 75.41% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 10.18%.
- The last Return On Invested Capital (9.17%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- The Profit Margin of ABL (14.72%) is better than 88.52% of its industry peers.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- The Operating Margin of ABL (18.85%) is better than 78.69% of its industry peers.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- ABL has a Gross Margin (56.68%) which is in line with its industry peers.
- ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABL is destroying value.
- ABL has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, ABL has less shares outstanding
- Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
- ABL has an Altman-Z score of 4.87. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.87, ABL belongs to the best of the industry, outperforming 81.97% of the companies in the same industry.
- The Debt to FCF ratio of ABL is 1.75, which is an excellent value as it means it would take ABL, only 1.75 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.75, ABL belongs to the top of the industry, outperforming 81.97% of the companies in the same industry.
- A Debt/Equity ratio of 0.19 indicates that ABL is not too dependend on debt financing.
- The Debt to Equity ratio of ABL (0.19) is better than 72.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.87 |
ROIC/WACC0.89
WACC10.29%
2.3 Liquidity
- A Current Ratio of 1.58 indicates that ABL should not have too much problems paying its short term obligations.
- ABL's Current ratio of 1.58 is in line compared to the rest of the industry. ABL outperforms 50.82% of its industry peers.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Quick ratio (1.18) which is comparable to the rest of the industry.
- The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 10.28% over the past year.
- The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
- Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
- Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
- The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 19.71, ABL is valued on the expensive side.
- Based on the Price/Earnings ratio, ABL is valued a bit cheaper than 75.41% of the companies in the same industry.
- When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (25.35), we can say ABL is valued slightly cheaper.
- A Price/Forward Earnings ratio of 17.65 indicates a rather expensive valuation of ABL.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.61, ABL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.71 | ||
| Fwd PE | 17.65 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
- ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 67.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.82 | ||
| EV/EBITDA | 15.92 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.71
PEG (5Y)2.76
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABL.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.41%, ABL has a reasonable but not impressive dividend return.
- ABL's Dividend Yield is a higher than the industry average which is at 1.14.
- Compared to an average S&P500 Dividend Yield of 1.89, ABL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.41% |
5.2 History
- On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of ABL is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (3/31/2026, 7:00:00 PM)
88.28
-1.44 (-1.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap153.40B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target114.26 (29.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.41% |
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-8.26%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-4.38%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.71 | ||
| Fwd PE | 17.65 | ||
| P/S | 3.97 | ||
| P/FCF | 23.82 | ||
| P/OCF | 18.42 | ||
| P/B | 3.38 | ||
| P/tB | 7.81 | ||
| EV/EBITDA | 15.92 |
EPS(TTM)4.48
EY5.07%
EPS(NY)5
Fwd EY5.67%
FCF(TTM)3.71
FCFY4.2%
OCF(TTM)4.79
OCFY5.43%
SpS22.21
BVpS26.12
TBVpS11.31
PEG (NY)1.71
PEG (5Y)2.76
Graham Number51.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.87 |
F-Score6
WACC10.29%
ROIC/WACC0.89
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
How profitable is ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.
Is the dividend of ABBOTT LABORATORIES sustainable?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.